BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 3547113)

  • 21. Mutagenicity of pyrene in Salmonella.
    Matijasević Z; Zeiger E
    Mutat Res; 1985 Apr; 142(4):149-52. PubMed ID: 3885017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Difference in liver homogenates from Donryu, Fischer, Sprague-Dawley and Wistar strains of rat in the drug-metabolizing enzyme assay and the Salmonella/hepatic S9 activation test.
    Yoshikawa K; Nohmi T; Miyata R; Ishidate M; Ozawa N; Isobe M; Watabe T; Kada T; Kawachi T
    Mutat Res; 1982 Oct; 96(2-3):167-86. PubMed ID: 6755239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic, additive, and antagonistic mutagenic responses to binary mixtures of benzo(a)pyrene and benzo(e)pyrene as detected by strains TA98 and TA100 in the Salmonella/microsome assay.
    Hass BS; Brooks EE; Schumann KE; Dornfeld SS
    Environ Mutagen; 1981; 3(2):159-66. PubMed ID: 6263605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinol (vitamin A) inhibits the mutagenicity of o-aminoazotoluene activated by liver microsomes from several species in the Ames test.
    Victorin K; Busk L; Ahlborg UG
    Mutat Res; 1987 Jul; 179(1):41-8. PubMed ID: 3110607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic expression of aflatoxin metabolism. Effects of 3-methylcholanthrene and beta-naphthoflavone on hepatic microsomal metabolism and mutagenic activation of aflatoxins.
    Raina V; Williams CJ; Gurtoo HL
    Biochem Pharmacol; 1983 Dec; 32(24):3755-63. PubMed ID: 6318770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutagenesis in Salmonella after metabolic activation of carcinogenic azo dyes and their isomers by liver S9 from rats, mice and hamsters.
    Mori Y; Niwa T; Toyoshi K; Hirano K; Sugiura M
    Mutat Res; 1983 Aug; 121(2):95-102. PubMed ID: 6348534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutagenicity studies on fenitrothion in bacteria and mammalian cells.
    Hara M; Kogiso S; Yamada F; Kawamoto M; Yoshitake A; Miyamoto J
    Mutat Res; 1989 Jan; 222(1):53-61. PubMed ID: 2643032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The evaluation of mutagenicities of 19 structurally related aromatic amines and acetamides in Salmonella typhimurium TA98 and TA100.
    Connor TH; Ramanujam VM; Rinkus SJ; Legator MS; Trieff NM
    Mutat Res; 1983 Jul; 118(1-2):49-59. PubMed ID: 6346086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. H-2 modulation of aryl hydrocarbon hydroxylase induction and the mutagenicity of benzo(a)pyrene after 3-methylcholanthrene treatment.
    Brooks BA; Wassom DL; Babish JG
    Adv Exp Med Biol; 1986; 197():797-807. PubMed ID: 3532714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutagenicity of 3-chlorodibenzofuran and its metabolic activation.
    Matsumoto M; Ando M
    Environ Mol Mutagen; 1991; 17(2):104-11. PubMed ID: 2009865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microsomal activation of dibenzo[def,mno]chrysene (anthanthrene), a hexacyclic aromatic hydrocarbon without a bay-region, to mutagenic metabolites.
    Platt KL; Degenhardt C; Grupe S; Frank H; Seidel A
    Chem Res Toxicol; 2002 Mar; 15(3):332-42. PubMed ID: 11896680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of mutagenicity of trioxane and dioxolane in Salmonella typhimurium.
    Kowalski Z; Spiechowicz E; Barański B
    Mutat Res; 1984 Jun; 136(3):169-71. PubMed ID: 6377055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutagenicity of diphenylhydantoin and some of its metabolites towards salmonella typhimurium strains.
    Sezzano P; Raimondi A; Arboix M; Pantarotto C
    Mutat Res; 1982 Mar; 103(3-6):219-28. PubMed ID: 7045642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic activation of 3-nitroperylene in the Salmonella/S9 assay.
    Anderson JG; McCalla DR; Bryant DW; McCarry BE; Bromke AM
    Mutagenesis; 1987 Jul; 2(4):279-85. PubMed ID: 3325759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Some factors affecting mutant numbers in the Salmonella/microsome assay.
    Booth SC; Welch AM; Garner RC
    Carcinogenesis; 1980; 1(11):911-23. PubMed ID: 11219844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutagenicity of 2,6-dinitrotoluene and its metabolites, and their related compounds in Salmonella typhimurium.
    Sayama M; Mori M; Shirokawa T; Inoue M; Miyahara T; Kozuka H
    Mutat Res; 1989 Jul; 226(3):181-4. PubMed ID: 2664501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutagenicity of benzo[a]pyrene 7,8-dihydrodiol and 7,12-dimethylbenz[a]anthracene 3,4-dihydrodiol in S. typhimurium mediated by microsomes from rat liver and mouse skin.
    Camus AM; Pyerin WG; Grover PL; Sims P; Malaveille C; Bartsch H
    Chem Biol Interact; 1980 Nov; 32(3):257-65. PubMed ID: 6775825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo benzo(a)pyrene metabolism in rat liver and lung microsomes: effect of sodium selenite.
    Bompart G; Clamens S
    J Toxicol Clin Exp; 1990; 10(1):3-14. PubMed ID: 2163448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rat nasal tissue activation of benzo(a)pyrene and 2-aminoanthracene to mutagens in Salmonella typhimurium.
    Bond JA; Li AP
    Environ Mutagen; 1983; 5(3):311-8. PubMed ID: 6303770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of dietary casein levels on activation of promutagens in the spiral Salmonella mutagenicity assay. II. Studies with induced rat liver S9.
    Woodall GM; Dauterman WC; DeMarini DM
    Mutat Res; 1996 Jun; 360(2):127-43. PubMed ID: 8649465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.